Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Patients With Acute Myeloid Leukemia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02719574
What this trial is testing

Open-label Study of FT-2102 With or Without Azacitidine or Cytarabine in Patients With AML or MDS With an IDH1 Mutation

Who this might be right for
Acute Myeloid LeukemiaAcute Myelogenous LeukemiaMyelodysplastic Syndrome
Forma Therapeutics, Inc. 336
Not applicableNot Yet RecruitingNCT06906380
What this trial is testing

A Long-term Follow-up Study of Patients With ARD103 CAR-T Cell Therapies

Who this might be right for
Acute Myeloid Leukemia, in RelapseAcute Myeloid Leukemia, in Relapsed or RefractoryMDS (Myelodysplastic Syndrome)
ARCE Therapeutics, Inc. 49
Early research (Phase 1)UnknownNCT05703204
What this trial is testing

QLF32101 in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndrome

Who this might be right for
Acute Myeloid Leukemia and Myelodysplastic Syndrome
Qilu Pharmaceutical Co., Ltd. 122
Not applicableStudy completedNCT05488613
What this trial is testing

Healthcare Resource Utilization in Adults Diagnosed With Acute Myeloid Leukemia (AML)

Who this might be right for
Acute Myeloid Leukemia (AML)
Novartis Pharmaceuticals 81
Testing effectiveness (Phase 2)Active Not RecruitingNCT03192397
What this trial is testing

Chemotherapy, Total Body Irradiation, and Post-Transplant Cyclophosphamide in Reducing Rates of Graft Versus Host Disease in Patients With Hematologic Malignancies Undergoing Donor Stem Cell Transplant

Who this might be right for
Acute Myeloid Leukemia in RemissionAdult Acute Lymphoblastic Leukemia in Complete RemissionChronic Myelogenous Leukemia, BCR-ABL1 Positive in Remission+10 more
Roswell Park Cancer Institute
Testing effectiveness (Phase 2)Active Not RecruitingNCT06098313
What this trial is testing

HCT With PTCy in Higher-risk MDS

Who this might be right for
Patients With MDS, Acute Myeloid Leukemia (AML) Evolving From MDS, and Chronic Myelomonocytic Leukemia (CMML)
Asan Medical Center 113
Large-scale testing (Phase 3)Study completedNCT00428558
What this trial is testing

Timed-Sequential Induction in CBF-AML

Who this might be right for
Acute Myeloid Leukemia
Assistance Publique - Hôpitaux de Paris 200
Early research (Phase 1)UnknownNCT04766840
What this trial is testing

Donor-derived CAR-T Cells in the Treatment of AML Patients

Who this might be right for
AML
Beijing Immunochina Medical Science & Technology Co., Ltd. 9
Testing effectiveness (Phase 2)Study completedNCT02666950
What this trial is testing

WEE1 Inhibitor AZD1775 With or Without Cytarabine in Treating Patients With Advanced Acute Myeloid Leukemia or Myelodysplastic Syndrome

Who this might be right for
Chronic Myelomonocytic LeukemiaMyelodysplastic Syndrome With Isolated Del(5q)Myelodysplastic/Myeloproliferative Neoplasm+3 more
Mayo Clinic 3
Testing effectiveness (Phase 2)Ended earlyNCT00053014
What this trial is testing

S0125, Chemotherapy, Total-Body Irradiation, and Peripheral Stem Cell Transplantation in Treating Older Patients With Acute Myeloid Leukemia

Who this might be right for
Leukemia
SWOG Cancer Research Network 5
Early research (Phase 1)Study completedNCT02326584
What this trial is testing

A Safety Study of SGN-CD33A in Combination With Standard-of-care in Patients With AML

Who this might be right for
Acute Myeloid LeukemiaAcute Myelogenous Leukemia
Seagen Inc. 116
Testing effectiveness (Phase 2)Study completedNCT00002547
What this trial is testing

Chemotherapy and Bone Marrow Transplantation in Treating Patients Acute Myeloid With Leukemia or Myelodysplastic Syndrome

Who this might be right for
LeukemiaMyelodysplastic Syndromes
Barbara Ann Karmanos Cancer Institute 280
Not applicableEnded earlyNCT00904514
What this trial is testing

Study of Previously Collected and Stored Tissue Samples From Patients Previously Enrolled in a Completed National Cancer Institute Clinical Trial

Who this might be right for
Cancer
National Institutes of Health Clinical Center (CC) 241
Testing effectiveness (Phase 2)Study completedNCT02550535
What this trial is testing

A Phase I/II Study of Gene-modified WT1 TCR Therapy in MDS & AML Patients

Who this might be right for
Myelodysplastic Syndromes (MDS)Acute Myeloid Leukaemia (AML)
Cell Medica Ltd 3
Not applicableUnknownNCT03600558
What this trial is testing

Efficacy of FLAG Regimen for the Treatment of Patients With AML

Who this might be right for
LeukemiaLeukemia, MyeloidLeukemia, Myeloid, Acute
Tianjin Medical University General Hospital 60
Not applicableStudy completedNCT03881826
What this trial is testing

Investigation of the Gut Microbiota in Patients With Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid LeukemiaCachexia
Université Catholique de Louvain 60
Testing effectiveness (Phase 2)Study completedNCT01175785
What this trial is testing

Infusion of Off-the-Shelf Expanded Cord Blood Cells to Augment Cord Blood Transplant in Patients With Hematologic Malignancies

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Myeloid Leukemia in RemissionAdult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities+17 more
Nohla Therapeutics, Inc. 15
Testing effectiveness (Phase 2)Study completedNCT00520208
What this trial is testing

Safety, Efficacy, & Pharmacokinetic Study of Tamibarotene to Treat Patients With Relapsed or Refractory APL

Who this might be right for
Acute Promyelocytic Leukemia
CytRx 15
Testing effectiveness (Phase 2)Study completedNCT01893320
What this trial is testing

Study of Vosaroxin and Decitabine in Older Patients With Acute Myeloid Leukemia and High-risk Myelodysplastic Syndrome

Who this might be right for
Leukemia
M.D. Anderson Cancer Center 66
Early research (Phase 1)Study completedNCT01001143
What this trial is testing

Intravenous (IV) Decitabine and Oral Bexarotene for Acute Myelogenous Leukemia (AML)

Who this might be right for
Leukemia, Myeloid, Acute
Washington University School of Medicine 19
Next Page
35